Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
Recruiting now · Phase 3
Conditions studied: Biliary Tract Cancer
In brief
The purpose of this study is to measure the efficacy and safety of T-DXd with rilvegostomig or T-DXd monotherapy compared with gemcitabine plus cisplatin and durvalumab in patients with advanced treatment naïve HER2-expressing BTC.
Key facts
- Study ID
- NCT06467357
- Run by
- AstraZeneca
- People needed
- 620
- Starts
- 2024-08-12
- Expected to finish
- 2029-05-16
- Last updated by the study team
- 2026-07-07
Who can join
Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Cleveland, Ohio, United States (enrolling)
- Research Site — Dallas, Texas, United States (enrolling)
- Research Site — Rochester, Minnesota, United States (enrolling)
- Research Site — White Plains, New York, United States (enrolling)
- Research Site — Columbus, Ohio, United States (enrolling)
- Research Site — Greenville, South Carolina, United States (enrolling)
- Research Site — Los Angeles, California, United States (enrolling)
- Research Site — Fullerton, California, United States (enrolling)
- Research Site — La Jolla, California, United States (enrolling)
- Research Site — St Louis, Missouri, United States (enrolling)
- Research Site — Tucson, Arizona, United States (enrolling)
- Research Site — Jacksonville, Florida, United States (enrolling)
- Research Site — St. Petersburg, Florida, United States (enrolling)
- Research Site — Los Angeles, California, United States (enrolling)
- Research Site — West Palm Beach, Florida, United States (enrolling)
- Research Site — Atlanta, Georgia, United States (enrolling)
- Research Site — San Francisco, California, United States (enrolling)
- Research Site — Chicago, Illinois, United States (enrolling)
- Research Site — Niles, Illinois, United States (enrolling)
- Research Site — Towson, Maryland, United States (enrolling)
- Research Site — Scottsdale, Arizona, United States (enrolling)
- Research Site — Kansas City, Missouri, United States (enrolling)
- Research Site — Fort Myers, Florida, United States (enrolling)
- Research Site — Grand Rapids, Michigan, United States (enrolling)
- Research Site — Fort Worth, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.